Skip to content
← Full study record

NCT00708721 · OUTCOME

Response of MDS Patients Treated With Low Dose Daily Oral Clofarabine.

Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia · Source last updated 2017-06-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
approximately 4 years

What was measured

Stable disease is defined as failure to achieve at least PR, but no evidence of progression for \> 8 weeks.

Analysis population: Of 11 patients, 9 were evaluable for response. Two patients had stable disease responses.

Groups in this outcome

All Evaluable Patients

All evaluable patients. Eleven patients were enrolled, but only nine were evaluable.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Evaluable Patients9

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
All Evaluable Patients2Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        2
denoms
  1. counts
    1. group Id
      OG000
      value
      9
    units
    Participants
description
Stable disease is defined as failure to achieve at least PR, but no evidence of progression for \> 8 weeks.
groups
  1. description
    All evaluable patients. Eleven patients were enrolled, but only nine were evaluable.
    id
    OG000
    title
    All Evaluable Patients
param Type
COUNT_OF_PARTICIPANTS
population Description
Of 11 patients, 9 were evaluable for response. Two patients had stable disease responses.
reporting Status
POSTED
time Frame
approximately 4 years
title
Response of MDS Patients Treated With Low Dose Daily Oral Clofarabine.
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice